
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FB70A9AB81CDBA5307A9AB000C8D45FE.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="tlcr">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Translational Lung Cancer Research">
<meta name="citation_title" content="Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report">
<meta name="citation_author" content="So-Yun Kim">
<meta name="citation_author_institution" content="Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_author" content="Jisoo Lee">
<meta name="citation_author_institution" content="College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_author" content="Dongil Park">
<meta name="citation_author_institution" content="Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_author" content="Jeong Eun Lee">
<meta name="citation_author_institution" content="Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_author" content="Joo-Eun Lee">
<meta name="citation_author_institution" content="Department of Biomedical Research Institute, Chungnam National University Hospital, Daejeon, Korea;">
<meta name="citation_author" content="Hyun-Yi Kim">
<meta name="citation_author_institution" content="NGeneS Inc., Asan-Si, Gyeonggi-do, South Korea">
<meta name="citation_author" content="Da Hyun Kang">
<meta name="citation_author_institution" content="Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_author" content="Chaeuk Chung">
<meta name="citation_author_institution" content="Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;">
<meta name="citation_publication_date" content="2025 Mar 18">
<meta name="citation_volume" content="14">
<meta name="citation_issue" content="3">
<meta name="citation_firstpage" content="1021">
<meta name="citation_doi" content="10.21037/tlcr-2024-1071">
<meta name="citation_pmid" content="40248726">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/pdf/tlcr-14-03-1021.pdf">
<meta name="description" content="Metachronous lung cancers with distinct driver mutations are rare, particularly following targeted therapy. This report presents a unique case of tumor evolution in non-small cell lung cancer (NSCLC). A 73-year-old East Asian woman was diagnosed ...">
<meta name="og:title" content="Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Metachronous lung cancers with distinct driver mutations are rare, particularly following targeted therapy. This report presents a unique case of tumor evolution in non-small cell lung cancer (NSCLC). A 73-year-old East Asian woman was diagnosed ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12000955">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.21037/tlcr-2024-1071"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/tlcr-14-03-1021.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000955%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12000955/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12000955/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-tlcr.gif" alt="Translational Lung Cancer Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Translational Lung Cancer Research" title="Link to Translational Lung Cancer Research" shape="default" href="http://www.tlcr.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Transl Lung Cancer Res</button></div>. 2025 Mar 18;14(3):1021–1031. doi: <a href="https://doi.org/10.21037/tlcr-2024-1071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.21037/tlcr-2024-1071</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Transl%20Lung%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Transl%20Lung%20Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Transl%20Lung%20Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Transl%20Lung%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Metachronous development of L858R and T790M EGFR mutations following ALK inhibitor therapy in stage IV lung adenocarcinoma: a case report</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20SY%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">So-Yun Kim</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">So-Yun Kim</span></h3>
<div class="p">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20SY%22%5BAuthor%5D" class="usa-link"><span class="name western">So-Yun Kim</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jisoo Lee</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jisoo Lee</span></h3>
<div class="p">
<sup>2</sup>College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jisoo Lee</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Dongil Park</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Dongil Park</span></h3>
<div class="p">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Park%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dongil Park</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20JE%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jeong Eun Lee</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jeong Eun Lee</span></h3>
<div class="p">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20JE%22%5BAuthor%5D" class="usa-link"><span class="name western">Jeong Eun Lee</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20JE%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Joo-Eun Lee</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Joo-Eun Lee</span></h3>
<div class="p">
<sup>3</sup>Department of Biomedical Research Institute, Chungnam National University Hospital, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20JE%22%5BAuthor%5D" class="usa-link"><span class="name western">Joo-Eun Lee</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20HY%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hyun-Yi Kim</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hyun-Yi Kim</span></h3>
<div class="p">
<sup>4</sup>NGeneS Inc., Asan-Si, Gyeonggi-do, South Korea</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kim%20HY%22%5BAuthor%5D" class="usa-link"><span class="name western">Hyun-Yi Kim</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20DH%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Da Hyun Kang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Da Hyun Kang</span></h3>
<div class="p">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kang%20DH%22%5BAuthor%5D" class="usa-link"><span class="name western">Da Hyun Kang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chung%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Chaeuk Chung</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Chaeuk Chung</span></h3>
<div class="p">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chung%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chaeuk Chung</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div id="aff2">
<sup>2</sup>College of Medicine, Chungnam National University, Daejeon, Korea;</div>
<div id="aff3">
<sup>3</sup>Department of Biomedical Research Institute, Chungnam National University Hospital, Daejeon, Korea;</div>
<div id="aff4">
<sup>4</sup>NGeneS Inc., Asan-Si, Gyeonggi-do, South Korea</div>
<div class="author-notes p">
<div class="fn" id="afn1"><p><em>Contributions:</em> (I) Conception and design: J Lee, SY Kim, DH Kang, C Chung; (II) Administrative support: D Park, C Chung; (III) Provision of study materials or patients: D Park, C Chung; (IV) Collection and assembly of data: J Lee, SY Kim, Jeong Eun Lee; (V) Data analysis and interpretation: J Lee, SY Kim, Jeong Eun Lee, Joo-Eun Lee, HY Kim, DH Kang, C Chung; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.</p></div>
<div class="fn" id="afn2">
<sup>#</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline"><em>Correspondence to:</em> Da Hyun Kang, MD, PhD; Chaeuk Chung, MD, PhD. Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, 282 Munhwa-ro, 35015, Daejeon, Korea. Email: <span>ibelieveu113@naver.com</span> or <span>ibelieveu113@cnuh.co.kr</span>; <span>universe7903@gmail.com</span>.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 11; Accepted 2025 Jan 27; Issue date 2025 Mar 31.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 AME Publishing Company. All rights reserved.</div>
<p><em>Open Access Statement:</em> This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc-nd/4.0</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12000955  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40248726/" class="usa-link">40248726</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Metachronous lung cancers with distinct driver mutations are rare, particularly following targeted therapy. This report presents a unique case of tumor evolution in non-small cell lung cancer (NSCLC).</p></section><section id="sec2"><h3 class="pmc_sec_title">Case Description</h3>
<p>A 73-year-old East Asian woman was diagnosed with stage IV anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinoma in the right middle lobe (RML). After 18 months of alectinib treatment, while the initial lesion regressed, a new nodule developed in the right upper lobe (RUL). Biopsy revealed adenocarcinoma with epidermal growth factor receptor (EGFR) L858R/T790M co-mutations without ALK rearrangement. We conducted a comparative analysis of genetic alterations in biopsies from 2022 and 2024 using targeted next-generation sequencing (NGS), revealing significant molecular evolution over time, with a marked increase in single nucleotide variants (SNVs) and copy number variants (CNVs) and distinct changes in key mutations such as ALK-EML4 and EGFR. The patient received stereotactic body radiotherapy (SBRT) for the new lesion while continuing alectinib, resulting in significant improvement until now.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusions</h3>
<p>This case represents the first documented occurrence of metachronous L858R and T790M EGFR mutations following ALK inhibitor therapy, highlighting the emergence of distinct driver mutations over time and reflecting temporal and spatial tumor heterogeneity. These findings underscore the importance of monitoring clonal evolution to guide tailored therapeutic strategies in NSCLC. Furthermore, re-biopsy is essential to assess tumor heterogeneity, identify potential drug resistance, and detect new mutations, ensuring that treatment strategies remain optimized for evolving disease conditions.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords: </strong> Case report, metachronous lung cancer, tumor heterogeneity, anaplastic lymphoma kinase inhibitor (ALK inhibitor), EGFR L858R/T790M co-mutation</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="ba"><h2 class="obj_head">Highlight box.</h2>
<section id="sec4"><h3 class="pmc_sec_title">Key findings</h3>
<p>• Metachronous development of T790M and L858R epidermal growth factor receptor (EGFR) co-mutations following anaplastic lymphoma kinase (ALK) inhibitor therapy in stage IV lung adenocarcinoma and personalized treatment strategies.</p></section><section id="sec5"><h3 class="pmc_sec_title">What is known and what is new?</h3>
<p>• ALK and EGFR mutations are key drivers in non-small cell lung cancer (NSCLC) and are generally mutually exclusive. Many studies described resistance to ALK inhibitors involves ALK-dependent mutations or bypass pathways like neuregulin 1-human epidermal growth factor receptor 3-EGFR. Concurrent ALK and EGFR mutations are rare, occurring in 0.9–1.3% of NSCLC cases.</p>
<p>• This is the first case showing EGFR L858R/T790M mutations emerging after ALK inhibitor therapy, with concurrent analysis using next-generation sequencing. The findings reveal tumor heterogeneity, clonal evolution, and the role of ALK inhibitors in promoting genomic instability, emphasizing the need for personalized therapeutic strategies to address temporal and spatial tumor heterogeneity.</p></section><section id="sec6"><h3 class="pmc_sec_title">What is the implication, and what should change now?</h3>
<p>• The case underscores the need for continuous monitoring of tumor genetic profiles through re-biopsy or liquid biopsy, particularly when new lesions appear during targeted therapy. This approach is important for distinguishing between true drug resistance and the development of a new, distinct tumor with different driver mutations.</p>
<p>• A paradigm shifts towards routine re-biopsy or molecular profiling of new lesions in patients undergoing targeted therapy is essential to optimize personalized treatment strategies. Additionally, greater reliance on non-invasive methods like liquid biopsy could be invaluable, especially in elderly or frail patients, to better capture the dynamic nature of cancer evolution without the need for direct tissue sampling.</p></section></section><section id="sec7"><h2 class="pmc_sec_title">Introduction</h2>
<p>A metachronous malignant neoplasm is defined as the occurrence of a second primary malignancy in the same patient, diagnosed at least six months after the initial tumor (<a href="#r1" class="usa-link" aria-describedby="r1">1</a>). It can be challenging to distinguish metachronous lung cancer from intrapulmonary metastasis, particularly when relying solely on histopathological results (<a href="#r2" class="usa-link" aria-describedby="r2">2</a>). Nevertheless, the identification of driver mutations at the genetic level through next-generation sequencing (NGS) can facilitate the differentiation between the two and the planning of an appropriate treatment plan (<a href="#r3" class="usa-link" aria-describedby="r3">3</a>).</p>
<p>Tumor heterogeneity describes the differences that were observed between tumors of the same type in different patients, as well as the differences between a primary tumor and a secondary tumor in a single individual, or among the cells within a single tumor. It has a number of potential causes, which can be classified into intrinsic and extrinsic factors. Intrinsic factors include genomic instability, epigenetic changes, plastic gene expression and alterations in signal transduction. Extrinsic factors encompass the tumor microenvironment, comprising tumor blood vessels, inflammatory cells and mesenchymal cells, which collectively contribute to an uneven surrounding environment (<a href="#r4" class="usa-link" aria-describedby="r4">4</a>). The spatial and temporal heterogeneity of tumors can help to elucidate the mechanisms underlying the acquisition of drug resistance due to tumor dynamic changes and the emergence of new cancers (<a href="#r5" class="usa-link" aria-describedby="r5">5</a>).</p>
<p>The dynamic nature of cancer and the development of polyclonal drug resistance highlight the growing importance of re-biopsies and liquid biopsies, such as blood, bronchoalveolar lavage fluid (BALF), cerebrospinal fluid. In this case study, we present the case of a patient with an anaplastic lymphoma kinase (ALK) rearrangement who initially showed improvement with ALK inhibitor treatment. However, a newly developed mass was observed, and a biopsy of the lesion revealed no ALK mutation, but the presence of L858R and T790M epidermal growth factor receptor (EGFR) mutations. This is the first reported case demonstrating the emergence of EGFR L858R and T790M mutations following ALK inhibitor therapy, analyzed using NGS. This case study particularly emphasizes the critical importance of rebiopsy and a thorough understanding of the genetic evolution of cancer and the mechanisms underlying drug resistance over time (<a href="#r6" class="usa-link" aria-describedby="r6">6</a>,<a href="#r7" class="usa-link" aria-describedby="r7">7</a>). We present this article in accordance with the CARE reporting checklist (available at <a href="https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/rc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/rc</a>).</p></section><section id="sec8"><h2 class="pmc_sec_title">Case presentation</h2>
<p>A 73-year-old East Asian woman was admitted to the Pulmonology Department of Chungnam National University Hospital in November 2022 for evaluation of an abnormal chest computed tomography (CT) scan. She had no respiratory symptoms like cough or dyspnea. Her medical history included only hypertension, with no other significant underlying diseases, and she had no history of smoking or a family history of cancer. The chest CT revealed a 1.1-cm spiculated nodule in right middle lobe (RML), as well as multiple pleural nodules with mild pleural thickening and fibrotic lesions in right upper lobe (RUL) (<a href="#f1" class="usa-link"><em>Figure 1A-1D</em></a>).</p>
<figure class="fig xbox font-sm" id="f1"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000955_tlcr-14-03-1021-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfa/12000955/6c7e1e663dee/tlcr-14-03-1021-f1.jpg" loading="lazy" height="1121" width="768" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Chest CT images at initial in November 2022 and before 2<sup>nd</sup> biopsy in July 2024. (A,B) Initial CT for main nodule in RML (yellow arrow), multiple other nodules (yellow arrowheads) and pleural thickening (red arrow). (C,D) Initial CT for lung fibrosis in RUL. (E,F) CT in July 2024 showing resolution of RML nodule (yellow arrow), multiple other nodules (yellow arrowheads) and pleural thickening (red arrow). (G,H) CT in July 2024 showing newly appeared consolidation with ground-glass opacity in RUL (blue arrow). CT, computed tomography; RML, right middle lobe; RUL, right upper lobe.</p></figcaption></figure><p>A linear endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed on the enlarged lymph node 7. Pathologic results showed metastatic adenocarcinoma with ALK rearrangement with wild type EGFR mutation and NGS showed echinoderm microtubule-associated protein-like 4 (EML 4)-ALK fusion. Positron emission tomography (PET)-CT revealed pleural, multiple enhancing nodules with lymph nodes metastasis, leading to a diagnosis of stage IV lung cancer (T2N2M1a).</p>
<p>Targeted mutation chemotherapy with alectinib was initiated and continued for a period of one and a half years. Follow-up chest CT scans during treatment with alectinib demonstrated a reduction in the lung mass and pleural metastatic lesions. In July 2024, the chest CT, the previously observed main mass in the RML, subpleural nodules, and pleural metastasis were no longer visible (<a href="#f1" class="usa-link"><em>Figure 1E,1F</em></a>). However, CT revealed a newly developed peribronchial consolidation with ground-glass opacity in the anterior segment of the RUL (<a href="#f1" class="usa-link"><em>Figure 1G,1H</em></a>). She underwent radial EBUS-guided transbronchial lung biopsy (TBLB) to obtain tissue and culture of the lesion. The pathologic analysis confirmed adenocarcinoma, revealing the absence of an ALK rearrangement and the presence of newly identified EGFR mutation, which was not detected in the initial primary tumor (<a href="#f2" class="usa-link"><em>Figure 2A-2D</em></a>). Furthermore, NGS of the second tumor identified an EGFR L858R and T790M co-mutation, along with a TP53 L194R mutation.</p>
<figure class="fig xbox font-sm" id="f2"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000955_tlcr-14-03-1021-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfa/12000955/93b9afe43f1b/tlcr-14-03-1021-f2.jpg" loading="lazy" height="594" width="751" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathological and immunohistochemical findings from the first biopsy of the mediastinal 7<sup>th</sup> lymph node and the second biopsy of the consolidative lesion in the RUL. (A) H&amp;E staining of the lymph node. (B) Positive for ALK stain of the lymph node. (C) H&amp;E staining of RUL consolidation. (D) Negative result for ALK stain of RUL consolidation. Scale bars: 1 mm (A,B) and 100 µm (C,D). ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; H&amp;E, hematoxylin and eosin; RUL, right upper lobe.</p></figcaption></figure><p>To perform a detailed analysis of the two cancers, we conducted a comparative assessment of the raw data obtained from targeted gene sequencing NGS, provided by GC Genome (Korea), for biopsies collected in 2022 and 2024 (<a href="#f3" class="usa-link"><em>Figure 3</em></a>; <a href="https://cdn.amegroups.cn/static/public/TLCR-2024-1071-Supplementary.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S1</a>). Targeted NGS, a focused approach for detecting specific genetic alterations, is highly effective in identifying clinically relevant mutations. In the 2022 biopsy, four copy number variants (CNVs), two single nucleotide variants (SNVs), and two fusions were detected. In contrast, the 2024 biopsy revealed a substantial increase in genetic alterations, with 59 CNVs, 190 SNVs, and no fusions identified (<a href="#f3" class="usa-link"><em>Figure 3A,3B</em></a>). Visualization of the top 20 mutations (<a href="#f3" class="usa-link"><em>Figure 3C</em></a>) demonstrated that the 2022 sample contained an ALK-EML4 rearrangement without any detectable EGFR mutations. Conversely, the 2024 sample exhibited SNVs and CNVs in ALK and EML4 but lacked the ALK-EML4 rearrangement. Notably, EGFR mutations, along with numerous additional mutations absent in the 2022 sample, were detected in the 2024 biopsy. These findings suggest that the genetic profiles of the tumors from 2022 and 2024 are distinct, reflecting significant molecular evolution over time.</p>
<figure class="fig xbox font-sm" id="f3"><h3 class="obj_head">Figure 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000955_tlcr-14-03-1021-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfa/12000955/13027b2bcef9/tlcr-14-03-1021-f3.jpg" loading="lazy" height="425" width="712" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>NGS analysis of genetic alterations in 2022 and 2024 tumor samples. (A) Venn diagram showing shared and unique mutations between 2022 and 2024 samples. (B) Comparison of mutation types reveals 4 CNVs, 4 SNVs, and 2 fusions in 2022, while 59 CNVs and 190 SNVs were detected in 2024, with no fusions. (C) Top 20 mutations indicate the presence of an ALK-EML4 rearrangement in 2022, while in 2024, SNVs and CNVs in ALK and EML4, as well as epidermal growth factor receptor mutations, were observed, but the ALK-EML4 rearrangement was absent. ALK, anaplastic lymphoma kinase; CNVs, copy number variants; EML4, echinoderm microtubule-associated protein-like 4; NGS, next-generation sequencing; SNVs, single nucleotide variants.</p></figcaption></figure><p>The patient was finally diagnosed with metachronous lung cancer with an EGFR L858R/T790M mutation, which had developed following a primary lesion with ALK rearrangement. As the previously identified lesions (<a href="#f4" class="usa-link"><em>Figure 4A-4C</em></a>) had all improved, the patient was responding well to the ALK tyrosine kinase inhibitor. Since there was no evidence of newly enlarged lymph nodes or other lesions outside the RUL (<a href="#f4" class="usa-link"><em>Figure 4D,4E</em></a>), the patient was considered to have localized disease. Therefore, it was decided to continue the ALK inhibitor while administering stereotactic body radiotherapy (SBRT) to the newly developed RUL lesion. Subsequent to SBRT, the follow-up chest CT scan demonstrated a considerable reduction in the dimensions of the RUL lesion, with only residual scarring (<a href="#f4" class="usa-link"><em>Figure 4F-4H</em></a>). Furthermore, PET-CT imaging demonstrated the absence of any hypermetabolic lung lesion. <a href="#f4" class="usa-link"><em>Figure 4I</em></a> illustrates the dynamic changes in cancer lesions observed during the treatment period. The yellow line represents the ALK rearrangement, which significantly decreased following treatment with the ALK inhibitor, Alectinib. In contrast, the blue line represents the emergence of the EGFR mutation (L858R/T790M) in the RUL, which gradually increased over time. Following SBRT to the RUL, the newly developed lesion showed a marked decrease in size, leaving only residual scarring with no metabolic activity observed on PET-CT. She has remained well with no evidence of recurrence to date. All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editorial office of this journal.</p>
<figure class="fig xbox font-sm" id="f4"><h3 class="obj_head">Figure 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000955_tlcr-14-03-1021-f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfa/12000955/179edf991012/tlcr-14-03-1021-f4.jpg" loading="lazy" height="526" width="800" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Time course of lung cancer. (A) Lung cancer in the RML (yellow arrow). (B) No consolidation or GGO observed in the RUL (blue arrow). (C) Multiple enhancing nodules and lymph nodes on PET-CT images. (D) Disappearance of RML lung cancer after 18 months of alectinib treatment (yellow arrow). (E) Newly developed RUL consolidation and GGO (blue arrow), with rebiopsy performed. (F) The RML nodule remains undetectable (yellow arrow) with continued alectinib treatment. (G) Shrinkage of the RUL consolidation following stereotactic body radiotherapy (blue arrow). (H) No significant uptake observed on PET-CT. (I) Graph for size of lesions. Anaplastic lymphoma kinase rearrangement lesion in RML (yellow line) decreased and disappear using alectinib. However, newly and defined epidermal growth factor receptor mutated lesion in RUL (blue line) developed and after SBRT, there was no uptake in PET-CT. ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; GGO, ground-glass opacity; PET-CT, positron emission tomography-computed tomography; RML, right middle lobe; RUL, right upper lobe; SBRT, stereotactic body radiotherapy.</p></figcaption></figure></section><section id="sec9"><h2 class="pmc_sec_title">Discussion</h2>
<p>Our case is distinguished by three significant characteristics that set it apart from other cases in the field. First, it was observed that a single patient exhibited both mutually exclusive EGFR and ALK mutations. Secondly, it is rare and noteworthy that a new EGFR mutation emerged following the use of an ALK inhibitor targeting the original ALK mutation. This highlights the complexity of tumor heterogeneity, clonal evolution, and selective pressure. To our knowledge, this is the first reported case demonstrating the emergence of EGFR L858R and T790M mutations following ALK inhibitor therapy, analyzed using NGS. Lastly, the concurrent <em>de novo</em> occurrence of both L858R and T790M mutations in a patient who had not previously received EGFR inhibitor treatment is remarkable.</p>
<p>EGFR and ALK mutations are key drivers in non-small cell lung cancer (NSCLC), and they are generally considered mutually exclusive (<a href="#r8" class="usa-link" aria-describedby="r8">8</a>). The occurrence of concomitant EGFR and ALK mutations within the same tumor lesion is rare, reported in only 0.9–1.3% of NSCLC patients (<a href="#r9" class="usa-link" aria-describedby="r9">9</a>,<a href="#r10" class="usa-link" aria-describedby="r10">10</a>). Cases in which different tumors harbor distinct EGFR and ALK mutations, as observed in our patient, are likely even less common and remain poorly documented. Also, this case demonstrates the emergence of distinct driver mutations in separate tumor clones over time, reflecting temporal and spatial tumor heterogeneity rather than concurrent dual oncogenic alterations. Treatment decisions in such scenarios can be particularly challenging, as most reported cases involve concurrent mutations within a single tumor lesion. In a case that is similar in some respects to ours, Yorozuya <em>et al.</em> reported a case with EGFR and ALK mutations in distinct lung lesions occurring simultaneously, underscoring the complexity of treatment. The initial surgical lung biopsy revealed stage IIB (pT3N0M0) EGFR-mutant adenocarcinoma, and a subsequent biopsy one month later identified a separate tumor as stage IA1 ALK-mutant adenocarcinoma. Gefitinib was initiated immediately after the first surgical biopsy. However, 11 months later, disease progression occurred in the ALK-mutant adenocarcinoma, prompting a third surgical biopsy. Treatment was then switched to alectinib, which subsequently led to the progression of the EGFR-mutant adenocarcinoma. Subsequently, alternating therapy with two tyrosine kinase inhibitors (TKIs) every 2 months was administered, resulting in a prolonged progression-free survival (PFS) of 39 months. This case highlights the need for individualized strategies in managing dual oncogenic drivers (<a href="#r11" class="usa-link" aria-describedby="r11">11</a>).</p>
<p>In our patient, re-biopsy for new lesion showed an EGFR mutated lung cancer, which raised the possibility of switching or adding to an EGFR-TKI. However, the lesion was confined to the RUL and the patient had demonstrated a favorable response to ALK inhibitors for existing lesions. Also, Won <em>et al.</em> reported that ALK inhibitors appear to be effective for patients with co-alterations (<a href="#r12" class="usa-link" aria-describedby="r12">12</a>). Wang <em>et al.</em> demonstrated that alectinib was more effective than EGFR-TKIs, with patients achieving partial remission and a PFS of 16 months, continuing to derive ongoing benefits (<a href="#r13" class="usa-link" aria-describedby="r13">13</a>). Hu <em>et al.</em> reported that when using EGFR-TKI the cancer progressed but using alectinib combined with SBRT led to a partial response (PR), with a ≥30% reduction in the maximum diameter of tumor target lesions maintained for at least 4 weeks (<a href="#r14" class="usa-link" aria-describedby="r14">14</a>). Consequently, we administered SBRT to the newly developed lesion in the RUL while maintaining alectinib treatment, which has effectively managed the patient’s condition without any further cancer recurrence to date.</p>
<p>The EGFR T790M mutation is primarily known as an acquired resistance mechanism, occurring in 50–60% of patients who develop resistance to first- and second-line EGFR-TKI therapy (<a href="#r15" class="usa-link" aria-describedby="r15">15</a>,<a href="#r16" class="usa-link" aria-describedby="r16">16</a>). However, the <em>de novo </em>T790M mutation is exceptionally rare, detected in only 2.59% of NSCLC patients harboring EGFR mutations (<a href="#r17" class="usa-link" aria-describedby="r17">17</a>). Although the precise prevalence is unknown, it is clear that the concurrent <em>de novo </em>occurrence of T790M and L858R mutations are extremely rare in EGFR-TKI treatment-naïve patients.</p>
<p>Several possibilities can be considered based on known resistance mechanisms. Resistance mechanisms can be classified into two main categories: ALK-dependent mechanisms (such as mutations in the ALK tyrosine kinase domain or amplification of the ALK gene) and ALK-independent mechanisms (including activation of bypass signaling pathways like EGFR, HER2, or MET, drug efflux pumps, or epithelial-to-mesenchymal transition) (<a href="#r6" class="usa-link" aria-describedby="r6">6</a>,<a href="#r18" class="usa-link" aria-describedby="r18">18</a>-<a href="#r20" class="usa-link" aria-describedby="r20">20</a>). In ALK-dependent mechanisms, continuous exposure to ALK inhibitors may select for resistant clones, complicating treatment (<a href="#r21" class="usa-link" aria-describedby="r21">21</a>). Patients with ALK rearrangement are typically treated with second-generation inhibitors like brigatinib or alectinib, but resistance mutations such as G1202R or I1171N often necessitate switching to lorlatinib, a third-generation inhibitor capable of overcoming multiple resistance mutations and penetrating the blood-brain barrier (<a href="#r18" class="usa-link" aria-describedby="r18">18</a>,<a href="#r22" class="usa-link" aria-describedby="r22">22</a>). Resistance process may also promote genomic instability, leading to new driver mutations through clonal selection and drug-induced genetic and epigenetic reprogramming (<a href="#r23" class="usa-link" aria-describedby="r23">23</a>). In ALK-independent mechanism, other studies have reported resistance emerging as a result of cell line prolonged exposure to, or patient treatment with, alectinib, with mechanisms associated with amplification of EGFR, HER2 and other receptors. Tan <em>et al.</em> showed that the mechanisms of resistance to second-generation ALK inhibitors, such as alectinib and ceritinib, using the H3122 NSCLC cell line harboring the EML4-ALK variant 1 fusion. The study revealed that prolonged treatment with these inhibitors did not lead to ALK kinase domain mutations, which are a common resistance mechanism for first-generation inhibitors like crizotinib. Instead, resistance was driven by the activation of alternative receptor tyrosine kinase (RTK) pathways, particularly the NRG1-HER3-EGFR axis (<a href="#r24" class="usa-link" aria-describedby="r24">24</a>). Jang <em>et al.</em> established the patient-derived NSCLC cell line, DFCI032, which harbors both EML4-ALK and activated EGFR. Study demonstrated that dual ALK/EGFR inhibitors, compound 7c, effectively target both ALK and EGFR, including the T790M mutation, preventing adaptive resistance (<a href="#r25" class="usa-link" aria-describedby="r25">25</a>). Similarly, Tani <em>et al.</em> highlighted that EGFR bypass signaling through TGFα overexpression induces alectinib resistance, proposing alectinib-afatinib combination therapy as a potential solution (<a href="#r26" class="usa-link" aria-describedby="r26">26</a>).</p>
<p>The cross-reactivity of TKIs between RTKs, particularly ALK and EGFR, is an important factor in resistance mechanisms. Structural overlap in the ATP-binding sites of ALK and EGFR may allow limited inhibitory effects of certain TKIs, such as alectinib, on EGFR. However, this cross-reactivity is typically insufficient to produce significant clinical activity against EGFR-driven tumors. Conversely, EGFR TKIs, such as osimertinib, are not known to exhibit substantial activity against ALK rearrangements. In this case, selective pressure from ALK inhibition and underlying genomic instability may have facilitated the emergence of EGFR mutations, highlighting the interplay between ALK and EGFR pathways in resistance development.</p>
<p>Although the exact mechanism underlying the emergence of an EGFR co-mutation following ALK inhibitor therapy in our case remains unclear, several plausible scenarios can be proposed. First, the primary tumor was already genetically heterogeneous, with the fastest-growing, ALK-rearranged components accounting for the lesions that were first identified in RML and treated. A more slowly growing subpopulation with EGFR driver mutations colonized RUL. Second, the second tumor may have evolved from the first, with treatment using an ALK inhibitor causing the selection of a tumor negative for ALK rearrangement. Third, an unforeseen mechanism, such as tumor instability, may have contributed to the emergence or selection of the new EGFR mutation following ALK inhibitor therapy.</p>
<p>However, the first scenario, which assumes that the tumor was genetically heterogeneous from the beginning with both ALK-rearranged and EGFR-mutant components, appears less likely given that no EGFR mutations were detected in the 2022 NGS dataset (<a href="#f3" class="usa-link"><em>Figure 3</em></a>). Instead, the subsequent emergence of an EGFR-mutant lesion suggests that temporal tumor heterogeneity likely developed due to selective pressure exerted by ALK inhibitor therapy. This therapeutic pressure may have suppressed ALK-dependent tumor clones, facilitating the proliferation of sub-clones harboring alternative driver mutations, such as EGFR. Moreover, the emergence of 154 new mutations and the loss of ALK rearrangement observed in the 2024 dataset (<a href="#f3" class="usa-link"><em>Figure 3A</em></a>) further support the hypothesis that alectinib drove clonal selection under therapeutic pressure, ultimately facilitating tumor evolution. Unlike previous studies that utilized patient-derived or established NSCLC cell lines to investigate resistance mechanisms (<a href="#r24" class="usa-link" aria-describedby="r24">24</a>-<a href="#r26" class="usa-link" aria-describedby="r26">26</a>), our study analyzed NGS data collected at two distinct time points (2022 and 2024) following ALK inhibitor therapy. This approach enabled a direct evaluation of both temporal and spatial tumor heterogeneity, providing clinically relevant insights into the evolution of resistance, including the emergence of new driver mutations such as EGFR. These findings underscore the complexity of managing patients with evolving tumor heterogeneity and highlight the necessity of further research into resistance mechanisms and optimized therapeutic strategies targeting multiple pathways.</p>
<p>The evolving nature of tumors underscores the critical importance of re-biopsy in exploring resistance mechanisms and genetic changes. This is exemplified by a reported case in which an ALK-rearranged lung adenocarcinoma progressed to express an EGFR L858R mutation, while the original ALK rearrangement was lost following treatment with ALK inhibitors (<a href="#r27" class="usa-link" aria-describedby="r27">27</a>). Additionally, histologic transformation from adenocarcinoma to small cell carcinoma or squamous cell carcinoma has also been observed during treatment (<a href="#r28" class="usa-link" aria-describedby="r28">28</a>-<a href="#r30" class="usa-link" aria-describedby="r30">30</a>). In our case, if the treatment regimen had been changed without performing a biopsy—under the assumption that the new lesion represented resistance to the ALK inhibitor—the EGFR co-mutated lesion in the RUL might not have responded effectively to the new therapy. Additionally, a critical window of opportunity for effective treatment could have been missed. This highlights the importance of conducting re-biopsy, even in patients receiving targeted therapies based on known mutations, when new lesions emerge. Re-biopsy is essential to assess tumor heterogeneity, identify potential drug resistance, and detect new mutations, ensuring that treatment strategies remain optimized for evolving disease conditions.</p>
<p>While re-biopsy is essential, it is not always feasible, especially in elderly or frail patients, and obtaining sufficient tissue can often be challenging. Additionally, it may pose a significant financial burden. However, liquid biopsies are ease of sampling, repeatability, and reduced invasiveness (<a href="#r31" class="usa-link" aria-describedby="r31">31</a>-<a href="#r33" class="usa-link" aria-describedby="r33">33</a>). Liquid biopsies analyzing circulating tumor cells (CTCs), cell free DNA (cfDNA) or extracellular vesicles (like exosomes) from body fluids (e.g., blood, urine, pleural effusions) or BALF have shown promising advantages of noninvasiveness and accessibility (<a href="#r31" class="usa-link" aria-describedby="r31">31</a>,<a href="#r34" class="usa-link" aria-describedby="r34">34</a>-<a href="#r36" class="usa-link" aria-describedby="r36">36</a>). Many studies described the usefulness and high detection quality about liquid biopsy. For example, the pooled diagnostic performance of CTCs for detecting lung cancer showed a sensitivity of 0.72 [95% confidence interval (CI): 0.65–0.79] and specificity of 0.96 (95% CI: 0.91–0.98) (<a href="#r37" class="usa-link" aria-describedby="r37">37</a>). Zhang <em>et al.</em> (<a href="#r38" class="usa-link" aria-describedby="r38">38</a>) and Kim <em>et al.</em> (<a href="#r31" class="usa-link" aria-describedby="r31">31</a>) showed soluble programmed death ligand 1 (sPD-L1) correlated level of PD-L1 expression in NSCLC. Oh <em>et al.</em> (<a href="#r39" class="usa-link" aria-describedby="r39">39</a>) and Cheng <em>et al.</em> (<a href="#r40" class="usa-link" aria-describedby="r40">40</a>) showed sPD-L1 is predictive and prognostic biomarker in cancer. Qiu <em>et al.</em> (<a href="#r41" class="usa-link" aria-describedby="r41">41</a>) and Luo <em>et al.</em> (<a href="#r42" class="usa-link" aria-describedby="r42">42</a>) described cfDNA for EGFR mutation has a high diagnostic accuracy. The sensitivity of cfDNA has been shown to be 67.4% and 62%, respectively, and the specificity of 93.5% and 95.9%, respectively. In our case, the patient was in a suitable condition for rebiopsy via bronchoscopy, which successfully detected the new EGFR mutation. Therefore, EGFR testing using cfDNA from blood was not performed. However, in patients for whom rebiopsy is challenging, liquid biopsy techniques, such as EGFR detection through cfDNA analysis from blood, could be a useful alternative. However, liquid biopsy has some limitation like lack of standardization, easily fragility, and low concentration of some molecules in the body fluid (<a href="#r32" class="usa-link" aria-describedby="r32">32</a>). Ongoing research aims to utilize liquid biopsies to better understand tumor heterogeneity and predict lung cancer progression and changes in characteristics.</p>
<p>Lung cancer remains a heterogeneous and complex disease, with its mechanisms of resistance not fully understood. Conducting further research on this rare molecular shift is essential for providing optimal treatment for patients. In particular, evaluating new lesions through rebiopsy is crucial; thus, the continued development of diagnostic techniques that do not require direct tissue acquisition is equally important. Ultimately, this case reinforces the need for personalized approaches, adaptability, and regular monitoring in cancer therapeutic strategies, as tumors evolve over time. The dynamic transformation of the tumor highlights the critical importance of customizing treatment plans based on the unique characteristics of each patient’s tumor and their response to therapy.</p></section><section id="sec10"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This case presents a rare instance of tumor evolution in NSCLC, where an initially ALK-rearranged lung adenocarcinoma treated with an ALK tyrosine kinase inhibitor subsequently developed metachronous cancer with EGFR L858R/T790M co-mutations. These findings underscore the critical importance of re-biopsy in understanding tumor evolution and reflect the emergence of distinct driver mutations in separate tumor clones over time, illustrating temporal and spatial tumor heterogeneity. Such insights emphasize the necessity of personalized treatment approaches tailored to each patient and the significance of continuous molecular assessment in developing effective targeted therapies.</p></section><section id="sec11"><h2 class="pmc_sec_title">Supplementary</h2>
<section class="sm xbox font-sm" id="supplementary-material1"><div class="caption p"><p>The article’s supplementary files as</p></div></section><section class="sm xbox font-sm" id="su1"><div class="media p" id="d67e550">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-rc.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-rc.pdf</a><sup> (95.8KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div>
<div class="media p" id="d67e553">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-coif.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-coif.pdf</a><sup> (973.9KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div>
<div class="media p" id="d67e556">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-supplementary.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-supplementary.pdf</a><sup> (45.6KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>None.</p></section><section id="notes1"><p><em>Ethical Statement:</em> The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The authors have no conflicts of interest to declare. All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editorial office of this journal.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><em>Reporting Checklist:</em> The authors have completed the CARE reporting checklist. Available at <a href="https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/rc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/rc</a></p></div>
<div class="fn p" id="fn4"><p><em>Funding:</em> This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (No. 2022R1A2C2010148), the Korea Health Technology R&amp;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &amp; Welfare, Republic of Korea (No. RS-2020-KH088690).</p></div>
<div class="fn p" id="fn5"><p><em>Conflicts of Interest:</em> All authors have completed the ICMJE uniform disclosure form (available at <a href="https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/coif" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/coif</a>). H.Y.K. is an employee of NGeneS Inc., a for-profit company. This affiliation has been disclosed, and no direct financial support or involvement from NGeneS Inc. has influenced the study’s design, data collection, analysis, nor manuscript preparation. The other authors have no conflicts of interest to declare.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="r1">
<span class="label">1.</span><cite>Karthikeyan VS, Sistla SC, Srinivasan R, et al. 
Metachronous multiple primary malignant neoplasms of the stomach and the breast: report of two cases with review of literature.
Int Surg
2014;99:52-5. 10.9738/INTSURG-D-13-00056.1
</cite> [<a href="https://doi.org/10.9738/INTSURG-D-13-00056.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3897342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24444270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Surg&amp;title=Metachronous%20multiple%20primary%20malignant%20neoplasms%20of%20the%20stomach%20and%20the%20breast:%20report%20of%20two%20cases%20with%20review%20of%20literature.&amp;author=VS%20Karthikeyan&amp;author=SC%20Sistla&amp;author=R%20Srinivasan&amp;volume=99&amp;publication_year=2014&amp;pages=52-5&amp;pmid=24444270&amp;doi=10.9738/INTSURG-D-13-00056.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r2">
<span class="label">2.</span><cite>Murphy SJ, Harris FR, Kosari F, et al. 
Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer.
J Thorac Oncol
2019;14:1567-82. 10.1016/j.jtho.2019.05.008
</cite> [<a href="https://doi.org/10.1016/j.jtho.2019.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31103780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Using%20Genomics%20to%20Differentiate%20Multiple%20Primaries%20From%20Metastatic%20Lung%20Cancer.&amp;author=SJ%20Murphy&amp;author=FR%20Harris&amp;author=F%20Kosari&amp;volume=14&amp;publication_year=2019&amp;pages=1567-82&amp;pmid=31103780&amp;doi=10.1016/j.jtho.2019.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r3">
<span class="label">3.</span><cite>Hu Y, Ren S, Chen C, et al. 
Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
Thorac Cancer
2020;11:2018-22. 10.1111/1759-7714.13458
</cite> [<a href="https://doi.org/10.1111/1759-7714.13458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7327678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32415761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Metachronous%20primary%20lung%20adenocarcinomas%20harboring%20distinct%20KRAS%20mutations.&amp;author=Y%20Hu&amp;author=S%20Ren&amp;author=C%20Chen&amp;volume=11&amp;publication_year=2020&amp;pages=2018-22&amp;pmid=32415761&amp;doi=10.1111/1759-7714.13458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r4">
<span class="label">4.</span><cite>Sun XX, Yu Q. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.
Acta Pharmacol Sin
2015;36:1219-27. 10.1038/aps.2015.92
</cite> [<a href="https://doi.org/10.1038/aps.2015.92" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4648179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26388155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharmacol%20Sin&amp;title=Intra-tumor%20heterogeneity%20of%20cancer%20cells%20and%20its%20implications%20for%20cancer%20treatment.&amp;author=XX%20Sun&amp;author=Q%20Yu&amp;volume=36&amp;publication_year=2015&amp;pages=1219-27&amp;pmid=26388155&amp;doi=10.1038/aps.2015.92&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r5">
<span class="label">5.</span><cite>Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies.
Nat Rev Clin Oncol
2018;15:81-94. 10.1038/nrclinonc.2017.166
</cite> [<a href="https://doi.org/10.1038/nrclinonc.2017.166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29115304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Tumour%20heterogeneity%20and%20resistance%20to%20cancer%20therapies.&amp;author=I%20Dagogo-Jack&amp;author=AT%20Shaw&amp;volume=15&amp;publication_year=2018&amp;pages=81-94&amp;pmid=29115304&amp;doi=10.1038/nrclinonc.2017.166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r6">
<span class="label">6.</span><cite>Tabbò F, Reale ML, Bironzo P, et al. 
Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won.
Transl Lung Cancer Res
2020;9:2545-56. 10.21037/tlcr-20-372
</cite> [<a href="https://doi.org/10.21037/tlcr-20-372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7815358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33489817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Lung%20Cancer%20Res&amp;title=Resistance%20to%20anaplastic%20lymphoma%20kinase%20inhibitors:%20knowing%20the%20enemy%20is%20half%20the%20battle%20won.&amp;author=F%20Tabb%C3%B2&amp;author=ML%20Reale&amp;author=P%20Bironzo&amp;volume=9&amp;publication_year=2020&amp;pages=2545-56&amp;pmid=33489817&amp;doi=10.21037/tlcr-20-372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r7">
<span class="label">7.</span><cite>Scheffler M, Wiesweg M, Michels S, et al. 
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications.
Lung Cancer
2022;168:10-20. 10.1016/j.lungcan.2022.04.006
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2022.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35461051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Rebiopsy%20in%20advanced%20non-small%20cell%20lung%20cancer,%20clinical%20relevance%20and%20prognostic%20implications.&amp;author=M%20Scheffler&amp;author=M%20Wiesweg&amp;author=S%20Michels&amp;volume=168&amp;publication_year=2022&amp;pages=10-20&amp;pmid=35461051&amp;doi=10.1016/j.lungcan.2022.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r8">
<span class="label">8.</span><cite>Gainor JF, Varghese AM, Ou SH, et al. 
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.
Clin Cancer Res
2013;19:4273-81. 10.1158/1078-0432.CCR-13-0318
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-0318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3874127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23729361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=ALK%20rearrangements%20are%20mutually%20exclusive%20with%20mutations%20in%20EGFR%20or%20KRAS:%20an%20analysis%20of%201,683%20patients%20with%20non-small%20cell%20lung%20cancer.&amp;author=JF%20Gainor&amp;author=AM%20Varghese&amp;author=SH%20Ou&amp;volume=19&amp;publication_year=2013&amp;pages=4273-81&amp;pmid=23729361&amp;doi=10.1158/1078-0432.CCR-13-0318&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r9">
<span class="label">9.</span><cite>Yang JJ, Zhang XC, Su J, et al. 
Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.
Clin Cancer Res
2014;20:1383-92. 10.1158/1078-0432.CCR-13-0699
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-0699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24443522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Lung%20cancers%20with%20concomitant%20EGFR%20mutations%20and%20ALK%20rearrangements:%20diverse%20responses%20to%20EGFR-TKI%20and%20crizotinib%20in%20relation%20to%20diverse%20receptors%20phosphorylation.&amp;author=JJ%20Yang&amp;author=XC%20Zhang&amp;author=J%20Su&amp;volume=20&amp;publication_year=2014&amp;pages=1383-92&amp;pmid=24443522&amp;doi=10.1158/1078-0432.CCR-13-0699&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r10">
<span class="label">10.</span><cite>Lee JK, Kim TM, Koh Y, et al. 
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation.
Lung Cancer
2012;77:460-3. 10.1016/j.lungcan.2012.04.012
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2012.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22622260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Differential%20sensitivities%20to%20tyrosine%20kinase%20inhibitors%20in%20NSCLC%20harboring%20EGFR%20mutation%20and%20ALK%20translocation.&amp;author=JK%20Lee&amp;author=TM%20Kim&amp;author=Y%20Koh&amp;volume=77&amp;publication_year=2012&amp;pages=460-3&amp;pmid=22622260&amp;doi=10.1016/j.lungcan.2012.04.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r11">
<span class="label">11.</span><cite>Yorozuya T, Nagano Y, Chiba H, et al. 
Repeated treatment with gefitinib and alectinib in a patient with multiple EGFR-mutant and ALK-mutant lung adenocarcinomas: A case report.
Respir Med Case Rep
2021;32:101378. 10.1016/j.rmcr.2021.101378
</cite> [<a href="https://doi.org/10.1016/j.rmcr.2021.101378" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7941149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33732615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Respir%20Med%20Case%20Rep&amp;title=Repeated%20treatment%20with%20gefitinib%20and%20alectinib%20in%20a%20patient%20with%20multiple%20EGFR-mutant%20and%20ALK-mutant%20lung%20adenocarcinomas:%20A%20case%20report.&amp;author=T%20Yorozuya&amp;author=Y%20Nagano&amp;author=H%20Chiba&amp;volume=32&amp;publication_year=2021&amp;pages=101378&amp;pmid=33732615&amp;doi=10.1016/j.rmcr.2021.101378&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r12">
<span class="label">12.</span><cite>Won JK, Keam B, Koh J, et al. 
Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.
Ann Oncol
2015;26:348-54. 10.1093/annonc/mdu530
</cite> [<a href="https://doi.org/10.1093/annonc/mdu530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25403583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Concomitant%20ALK%20translocation%20and%20EGFR%20mutation%20in%20lung%20cancer:%20a%20comparison%20of%20direct%20sequencing%20and%20sensitive%20assays%20and%20the%20impact%20on%20responsiveness%20to%20tyrosine%20kinase%20inhibitor.&amp;author=JK%20Won&amp;author=B%20Keam&amp;author=J%20Koh&amp;volume=26&amp;publication_year=2015&amp;pages=348-54&amp;pmid=25403583&amp;doi=10.1093/annonc/mdu530&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r13">
<span class="label">13.</span><cite>Wang H, Zhu S, Li Z, et al. 
Lung adenocarcinoma with EGFR 19Del and an ALK rearrangement benefits from alectinib instead of an EGFR-TKI: A case report.
Medicine (Baltimore)
2022;101:e30316. 10.1097/MD.0000000000030316
</cite> [<a href="https://doi.org/10.1097/MD.0000000000030316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9439748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36107507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine%20(Baltimore)&amp;title=Lung%20adenocarcinoma%20with%20EGFR%2019Del%20and%20an%20ALK%20rearrangement%20benefits%20from%20alectinib%20instead%20of%20an%20EGFR-TKI:%20A%20case%20report.&amp;author=H%20Wang&amp;author=S%20Zhu&amp;author=Z%20Li&amp;volume=101&amp;publication_year=2022&amp;pages=e30316&amp;pmid=36107507&amp;doi=10.1097/MD.0000000000030316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r14">
<span class="label">14.</span><cite>Hu H, Tan S, Xie M, et al. 
Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer.
Front Pharmacol
2023;14:1167959. 10.3389/fphar.2023.1167959
</cite> [<a href="https://doi.org/10.3389/fphar.2023.1167959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10495838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37705536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Case%20report:%20Concomitant%20EGFR%20mutation%20and%20ALK%20rearrangement%20in%20non-small%20cell%20lung%20cancer.&amp;author=H%20Hu&amp;author=S%20Tan&amp;author=M%20Xie&amp;volume=14&amp;publication_year=2023&amp;pages=1167959&amp;pmid=37705536&amp;doi=10.3389/fphar.2023.1167959&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r15">
<span class="label">15.</span><cite>Kosaka T, Yatabe Y, Endoh H, et al. 
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.
Clin Cancer Res
2006;12:5764-9. 10.1158/1078-0432.CCR-06-0714
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-06-0714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17020982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Analysis%20of%20epidermal%20growth%20factor%20receptor%20gene%20mutation%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20and%20acquired%20resistance%20to%20gefitinib.&amp;author=T%20Kosaka&amp;author=Y%20Yatabe&amp;author=H%20Endoh&amp;volume=12&amp;publication_year=2006&amp;pages=5764-9&amp;pmid=17020982&amp;doi=10.1158/1078-0432.CCR-06-0714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r16">
<span class="label">16.</span><cite>Chhouri H, Alexandre D, Grumolato L.
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer.
Cancers (Basel)
2023;15:504. 10.3390/cancers15020504
</cite> [<a href="https://doi.org/10.3390/cancers15020504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9856371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36672453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Mechanisms%20of%20Acquired%20Resistance%20and%20Tolerance%20to%20EGFR%20Targeted%20Therapy%20in%20Non-Small%20Cell%20Lung%20Cancer.&amp;author=H%20Chhouri&amp;author=D%20Alexandre&amp;author=L.%20Grumolato&amp;volume=15&amp;publication_year=2023&amp;pages=504&amp;pmid=36672453&amp;doi=10.3390/cancers15020504&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r17">
<span class="label">17.</span><cite>Panda GS, Noronha V, Shah D, et al. 
Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer.
Ecancermedicalscience
2022;16:1385.
</cite> [<a href="https://doi.org/10.3332/ecancer.2022.1385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9300400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35919239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ecancermedicalscience&amp;title=Treatment%20pattern%20and%20outcomes%20in%20de%20novo%20T790M-mutated%20non-small%20cell%20lung%20cancer.&amp;author=GS%20Panda&amp;author=V%20Noronha&amp;author=D%20Shah&amp;volume=16&amp;publication_year=2022&amp;pages=1385&amp;pmid=35919239&amp;doi=10.3332/ecancer.2022.1385&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r18">
<span class="label">18.</span><cite>Gainor JF, Dardaei L, Yoda S, et al. 
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.
Cancer Discov
2016;6:1118-33. 10.1158/2159-8290.CD-16-0596
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-16-0596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5050111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27432227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=Molecular%20Mechanisms%20of%20Resistance%20to%20First-%20and%20Second-Generation%20ALK%20Inhibitors%20in%20ALK-Rearranged%20Lung%20Cancer.&amp;author=JF%20Gainor&amp;author=L%20Dardaei&amp;author=S%20Yoda&amp;volume=6&amp;publication_year=2016&amp;pages=1118-33&amp;pmid=27432227&amp;doi=10.1158/2159-8290.CD-16-0596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r19">
<span class="label">19.</span><cite>McCoach CE, Le AT, Gowan K, et al. 
Resistance Mechanisms to Targeted Therapies in ROS1(+) and ALK(+) Non-small Cell Lung Cancer.
Clin Cancer Res
2018;24:3334-47. 10.1158/1078-0432.CCR-17-2452
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-17-2452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6050099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29636358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Resistance%20Mechanisms%20to%20Targeted%20Therapies%20in%20ROS1(+)%20and%20ALK(+)%20Non-small%20Cell%20Lung%20Cancer.&amp;author=CE%20McCoach&amp;author=AT%20Le&amp;author=K%20Gowan&amp;volume=24&amp;publication_year=2018&amp;pages=3334-47&amp;pmid=29636358&amp;doi=10.1158/1078-0432.CCR-17-2452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r20">
<span class="label">20.</span><cite>Lin JJ, Riely GJ, Shaw AT. Targeting ALK: Precision Medicine Takes on Drug Resistance.
Cancer Discov
2017;7:137-55. 10.1158/2159-8290.CD-16-1123
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-16-1123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5296241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28122866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=Targeting%20ALK:%20Precision%20Medicine%20Takes%20on%20Drug%20Resistance.&amp;author=JJ%20Lin&amp;author=GJ%20Riely&amp;author=AT%20Shaw&amp;volume=7&amp;publication_year=2017&amp;pages=137-55&amp;pmid=28122866&amp;doi=10.1158/2159-8290.CD-16-1123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r21">
<span class="label">21.</span><cite>Bhang HE, Ruddy DA, Krishnamurthy Radhakrishna V, et al. 
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding.
Nat Med
2015;21:440-8. 10.1038/nm.3841
</cite> [<a href="https://doi.org/10.1038/nm.3841" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25849130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Studying%20clonal%20dynamics%20in%20response%20to%20cancer%20therapy%20using%20high-complexity%20barcoding.&amp;author=HE%20Bhang&amp;author=DA%20Ruddy&amp;author=V%20Krishnamurthy%20Radhakrishna&amp;volume=21&amp;publication_year=2015&amp;pages=440-8&amp;pmid=25849130&amp;doi=10.1038/nm.3841&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r22">
<span class="label">22.</span><cite>Yoda S, Lin JJ, Lawrence MS, et al. 
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.
Cancer Discov
2018;8:714-29. 10.1158/2159-8290.CD-17-1256
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-17-1256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5984716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29650534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=Sequential%20ALK%20Inhibitors%20Can%20Select%20for%20Lorlatinib-Resistant%20Compound%20ALK%20Mutations%20in%20ALK-Positive%20Lung%20Cancer.&amp;author=S%20Yoda&amp;author=JJ%20Lin&amp;author=MS%20Lawrence&amp;volume=8&amp;publication_year=2018&amp;pages=714-29&amp;pmid=29650534&amp;doi=10.1158/2159-8290.CD-17-1256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r23">
<span class="label">23.</span><cite>Vander Velde R, Yoon N, Marusyk V, et al. 
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures.
Nat Commun
2020;11:2393. 10.1038/s41467-020-16212-w
</cite> [<a href="https://doi.org/10.1038/s41467-020-16212-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7224215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32409712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Resistance%20to%20targeted%20therapies%20as%20a%20multifactorial,%20gradual%20adaptation%20to%20inhibitor%20specific%20selective%20pressures.&amp;author=R%20Vander%20Velde&amp;author=N%20Yoon&amp;author=V%20Marusyk&amp;volume=11&amp;publication_year=2020&amp;pages=2393&amp;pmid=32409712&amp;doi=10.1038/s41467-020-16212-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r24">
<span class="label">24.</span><cite>Tan AC, Vyse S, Huang PH. Exploiting receptor tyrosine kinase co-activation for cancer therapy.
Drug Discov Today
2017;22:72-84. 10.1016/j.drudis.2016.07.010
</cite> [<a href="https://doi.org/10.1016/j.drudis.2016.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5346155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27452454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discov%20Today&amp;title=Exploiting%20receptor%20tyrosine%20kinase%20co-activation%20for%20cancer%20therapy.&amp;author=AC%20Tan&amp;author=S%20Vyse&amp;author=PH%20Huang&amp;volume=22&amp;publication_year=2017&amp;pages=72-84&amp;pmid=27452454&amp;doi=10.1016/j.drudis.2016.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r25">
<span class="label">25.</span><cite>Jang J, Son JB, To C, et al. 
Discovery of a potent dual ALK and EGFR T790M inhibitor.
Eur J Med Chem
2017;136:497-510. 10.1016/j.ejmech.2017.04.079
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.04.079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5800871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28528303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Chem&amp;title=Discovery%20of%20a%20potent%20dual%20ALK%20and%20EGFR%20T790M%20inhibitor.&amp;author=J%20Jang&amp;author=JB%20Son&amp;author=C%20To&amp;volume=136&amp;publication_year=2017&amp;pages=497-510&amp;pmid=28528303&amp;doi=10.1016/j.ejmech.2017.04.079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r26">
<span class="label">26.</span><cite>Tani T, Yasuda H, Hamamoto J, et al. 
Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells.
Mol Cancer Ther
2016;15:162-71. 10.1158/1535-7163.MCT-15-0084
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-15-0084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26682573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&amp;title=Activation%20of%20EGFR%20Bypass%20Signaling%20by%20TGF%CE%B1%20Overexpression%20Induces%20Acquired%20Resistance%20to%20Alectinib%20in%20ALK-Translocated%20Lung%20Cancer%20Cells.&amp;author=T%20Tani&amp;author=H%20Yasuda&amp;author=J%20Hamamoto&amp;volume=15&amp;publication_year=2016&amp;pages=162-71&amp;pmid=26682573&amp;doi=10.1158/1535-7163.MCT-15-0084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r27">
<span class="label">27.</span><cite>Leung JKC, Kwok WC, Leung ACF, et al. 
Emerging EGFR-Mutated Subclones in a Patient With Metastatic ALK-Rearranged Lung Adenocarcinoma Treated With ALK-Targeted Therapy: A Case Report.
JTO Clin Res Rep
2023;4:100542. 10.1016/j.jtocrr.2023.100542
</cite> [<a href="https://doi.org/10.1016/j.jtocrr.2023.100542" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10368895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37502466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JTO%20Clin%20Res%20Rep&amp;title=Emerging%20EGFR-Mutated%20Subclones%20in%20a%20Patient%20With%20Metastatic%20ALK-Rearranged%20Lung%20Adenocarcinoma%20Treated%20With%20ALK-Targeted%20Therapy:%20A%20Case%20Report.&amp;author=JKC%20Leung&amp;author=WC%20Kwok&amp;author=ACF%20Leung&amp;volume=4&amp;publication_year=2023&amp;pages=100542&amp;pmid=37502466&amp;doi=10.1016/j.jtocrr.2023.100542&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r28">
<span class="label">28.</span><cite>Lin X, Qiu G, Li F, et al. 
Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy.
Front Immunol
2021;12:683202. 10.3389/fimmu.2021.683202
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.683202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8207139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34149722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Case%20Report:%20A%20Rare%20Case%20of%20Metachronous%20Multiple%20Primary%20Lung%20Cancers%20in%20a%20Patient%20With%20Successful%20Management%20by%20Switching%20From%20Anti-PD-1%20Therapy%20to%20Anti-PD-L1%20Therapy.&amp;author=X%20Lin&amp;author=G%20Qiu&amp;author=F%20Li&amp;volume=12&amp;publication_year=2021&amp;pages=683202&amp;pmid=34149722&amp;doi=10.3389/fimmu.2021.683202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r29">
<span class="label">29.</span><cite>Shao Y, Zhong DS, Guan SS. Histologic transformation of lung adenocarcinoma to squamous cell carcinoma after chemotherapy: two case reports.
Transl Cancer Res
2020;9:388-93. 10.21037/tcr.2019.11.34
</cite> [<a href="https://doi.org/10.21037/tcr.2019.11.34" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8798453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35117193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Cancer%20Res&amp;title=Histologic%20transformation%20of%20lung%20adenocarcinoma%20to%20squamous%20cell%20carcinoma%20after%20chemotherapy:%20two%20case%20reports.&amp;author=Y%20Shao&amp;author=DS%20Zhong&amp;author=SS%20Guan&amp;volume=9&amp;publication_year=2020&amp;pages=388-93&amp;pmid=35117193&amp;doi=10.21037/tcr.2019.11.34&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r30">
<span class="label">30.</span><cite>Woo CG, Son SM, Lee HC, et al. 
Histologic Changes in Non-Small Cell Lung Cancer under Various Treatments: A Comparison of Histology and Mutation Status in Serial Samples.
Cancer Res Treat
2022;54:737-43. 10.4143/crt.2021.773
</cite> [<a href="https://doi.org/10.4143/crt.2021.773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9296944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34583457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res%20Treat&amp;title=Histologic%20Changes%20in%20Non-Small%20Cell%20Lung%20Cancer%20under%20Various%20Treatments:%20A%20Comparison%20of%20Histology%20and%20Mutation%20Status%20in%20Serial%20Samples.&amp;author=CG%20Woo&amp;author=SM%20Son&amp;author=HC%20Lee&amp;volume=54&amp;publication_year=2022&amp;pages=737-43&amp;pmid=34583457&amp;doi=10.4143/crt.2021.773&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r31">
<span class="label">31.</span><cite>Kim SY, Park D, Sun P, et al. 
Prognostic and predictive significance of soluble programmed death ligand 1 in bronchoalveolar lavage fluid in stage IV non-small cell lung cancer.
Transl Lung Cancer Res
2024;13:1888-906. 10.21037/tlcr-24-392
</cite> [<a href="https://doi.org/10.21037/tlcr-24-392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11384500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39263019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Lung%20Cancer%20Res&amp;title=Prognostic%20and%20predictive%20significance%20of%20soluble%20programmed%20death%20ligand%201%20in%20bronchoalveolar%20lavage%20fluid%20in%20stage%20IV%20non-small%20cell%20lung%20cancer.&amp;author=SY%20Kim&amp;author=D%20Park&amp;author=P%20Sun&amp;volume=13&amp;publication_year=2024&amp;pages=1888-906&amp;pmid=39263019&amp;doi=10.21037/tlcr-24-392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r32">
<span class="label">32.</span><cite>Casagrande GMS, Silva MO, Reis RM, et al. 
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.
Int J Mol Sci
2023;24:2505. 10.3390/ijms24032505
</cite> [<a href="https://doi.org/10.3390/ijms24032505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9917347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36768828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Liquid%20Biopsy%20for%20Lung%20Cancer:%20Up-to-Date%20and%20Perspectives%20for%20Screening%20Programs.&amp;author=GMS%20Casagrande&amp;author=MO%20Silva&amp;author=RM%20Reis&amp;volume=24&amp;publication_year=2023&amp;pages=2505&amp;pmid=36768828&amp;doi=10.3390/ijms24032505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r33">
<span class="label">33.</span><cite>An HJ, Chon HJ, Kim C. Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors.
Int J Mol Sci
2021;22:9414. 10.3390/ijms22179414
</cite> [<a href="https://doi.org/10.3390/ijms22179414" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8430528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34502325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Peripheral%20Blood-Based%20Biomarkers%20for%20Immune%20Checkpoint%20Inhibitors.&amp;author=HJ%20An&amp;author=HJ%20Chon&amp;author=C%20Kim&amp;volume=22&amp;publication_year=2021&amp;pages=9414&amp;pmid=34502325&amp;doi=10.3390/ijms22179414&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r34">
<span class="label">34.</span><cite>Zhou J, Zhao C, Zhao J, et al. 
Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.
Thorac Cancer
2019;10:957-65. 10.1111/1759-7714.13035
</cite> [<a href="https://doi.org/10.1111/1759-7714.13035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6449239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30887673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Re-biopsy%20and%20liquid%20biopsy%20for%20patients%20with%20non-small%20cell%20lung%20cancer%20after%20EGFR-tyrosine%20kinase%20inhibitor%20failure.&amp;author=J%20Zhou&amp;author=C%20Zhao&amp;author=J%20Zhao&amp;volume=10&amp;publication_year=2019&amp;pages=957-65&amp;pmid=30887673&amp;doi=10.1111/1759-7714.13035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r35">
<span class="label">35.</span><cite>de Sousa VML, Carvalho L. Heterogeneity in Lung Cancer.
Pathobiology
2018;85:96-107. 10.1159/000487440
</cite> [<a href="https://doi.org/10.1159/000487440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29635240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathobiology&amp;title=Heterogeneity%20in%20Lung%20Cancer.&amp;author=VML%20de%20Sousa&amp;author=L%20Carvalho&amp;volume=85&amp;publication_year=2018&amp;pages=96-107&amp;pmid=29635240&amp;doi=10.1159/000487440&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r36">
<span class="label">36.</span><cite>Kim IA, Hur JY, Kim HJ, et al. 
Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC.
Cancers (Basel)
2022;14:2744. 10.3390/cancers14112744
</cite> [<a href="https://doi.org/10.3390/cancers14112744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9179452/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35681723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Extracellular%20Vesicle-Based%20Bronchoalveolar%20Lavage%20Fluid%20Liquid%20Biopsy%20for%20EGFR%20Mutation%20Testing%20in%20Advanced%20Non-Squamous%20NSCLC.&amp;author=IA%20Kim&amp;author=JY%20Hur&amp;author=HJ%20Kim&amp;volume=14&amp;publication_year=2022&amp;pages=2744&amp;pmid=35681723&amp;doi=10.3390/cancers14112744&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r37">
<span class="label">37.</span><cite>Zhao Q, Yuan Z, Wang H, et al. 
Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis.
J Int Med Res
2021;49:300060521994926. 10.1177/0300060521994926
</cite> [<a href="https://doi.org/10.1177/0300060521994926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7944544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33682521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Int%20Med%20Res&amp;title=Role%20of%20circulating%20tumor%20cells%20in%20diagnosis%20of%20lung%20cancer:%20a%20systematic%20review%20and%20meta-analysis.&amp;author=Q%20Zhao&amp;author=Z%20Yuan&amp;author=H%20Wang&amp;volume=49&amp;publication_year=2021&amp;pages=300060521994926&amp;pmid=33682521&amp;doi=10.1177/0300060521994926&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r38">
<span class="label">38.</span><cite>Zhang J, Gao J, Li Y, et al. 
Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics.
Thorac Cancer
2015;6:534-8. 10.1111/1759-7714.12247
</cite> [<a href="https://doi.org/10.1111/1759-7714.12247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4511334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26273411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cancer&amp;title=Circulating%20PD-L1%20in%20NSCLC%20patients%20and%20the%20correlation%20between%20the%20level%20of%20PD-L1%20expression%20and%20the%20clinical%20characteristics.&amp;author=J%20Zhang&amp;author=J%20Gao&amp;author=Y%20Li&amp;volume=6&amp;publication_year=2015&amp;pages=534-8&amp;pmid=26273411&amp;doi=10.1111/1759-7714.12247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r39">
<span class="label">39.</span><cite>Oh SY, Kim S, Keam B, et al. 
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment.
Sci Rep
2021;11:19712. 10.1038/s41598-021-99311-y
</cite> [<a href="https://doi.org/10.1038/s41598-021-99311-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8492653/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34611279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Soluble%20PD-L1%20is%20a%20predictive%20and%20prognostic%20biomarker%20in%20advanced%20cancer%20patients%20who%20receive%20immune%20checkpoint%20blockade%20treatment.&amp;author=SY%20Oh&amp;author=S%20Kim&amp;author=B%20Keam&amp;volume=11&amp;publication_year=2021&amp;pages=19712&amp;pmid=34611279&amp;doi=10.1038/s41598-021-99311-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r40">
<span class="label">40.</span><cite>Cheng S, Zheng J, Zhu J, et al. 
PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer.
Int J Biol Markers
2015;30:e364-8. 10.5301/jbm.5000170
</cite> [<a href="https://doi.org/10.5301/jbm.5000170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26349666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Biol%20Markers&amp;title=PD-L1%20gene%20polymorphism%20and%20high%20level%20of%20plasma%20soluble%20PD-L1%20protein%20may%20be%20associated%20with%20non-small%20cell%20lung%20cancer.&amp;author=S%20Cheng&amp;author=J%20Zheng&amp;author=J%20Zhu&amp;volume=30&amp;publication_year=2015&amp;pages=e364-8&amp;pmid=26349666&amp;doi=10.5301/jbm.5000170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r41">
<span class="label">41.</span><cite>Qiu M, Wang J, Xu Y, et al. 
Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
Cancer Epidemiol Biomarkers Prev
2015;24:206-12. 10.1158/1055-9965.EPI-14-0895
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-14-0895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25339418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Circulating%20tumor%20DNA%20is%20effective%20for%20the%20detection%20of%20EGFR%20mutation%20in%20non-small%20cell%20lung%20cancer:%20a%20meta-analysis.&amp;author=M%20Qiu&amp;author=J%20Wang&amp;author=Y%20Xu&amp;volume=24&amp;publication_year=2015&amp;pages=206-12&amp;pmid=25339418&amp;doi=10.1158/1055-9965.EPI-14-0895&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r42">
<span class="label">42.</span><cite>Luo J, Shen L, Zheng D. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
Sci Rep
2014;4:6269. 10.1038/srep06269
</cite> [<a href="https://doi.org/10.1038/srep06269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5385820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25201768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Diagnostic%20value%20of%20circulating%20free%20DNA%20for%20the%20detection%20of%20EGFR%20mutation%20status%20in%20NSCLC:%20a%20systematic%20review%20and%20meta-analysis.&amp;author=J%20Luo&amp;author=L%20Shen&amp;author=D%20Zheng&amp;volume=4&amp;publication_year=2014&amp;pages=6269&amp;pmid=25201768&amp;doi=10.1038/srep06269&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="tlcr-14-03-1021-prf"><section class="pmc-layout__citation font-secondary font-xs"><div>Transl Lung Cancer Res.</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Peer Review File</h1></hgroup><ul class="d-buttons inline-list"><li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li></ul>
<div class="d-panels font-secondary-light"><div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div></div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>Available at <a href="https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/prf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://tlcr.amegroups.com/article/view/10.21037/tlcr-2024-1071/prf</a></p>
<figure class="fig xbox font-sm" id="d67e1910"><div class="media p"><div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-prf.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-prf.pdf</a><sup> (185.1KB, pdf) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/d67e1910/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>The article’s supplementary files as</p></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-rc.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-rc.pdf</a><sup> (95.8KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-coif.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-coif.pdf</a><sup> (973.9KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12000955/bin/tlcr-14-03-1021-supplementary.pdf" data-ga-action="click_feat_suppl" class="usa-link">tlcr-14-03-1021-supplementary.pdf</a><sup> (45.6KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/tlcr-2024-1071</div>
</div></section></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Translational Lung Cancer Research are provided here courtesy of <strong>AME Publications</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.21037/tlcr-2024-1071"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/tlcr-14-03-1021.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12000955/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12000955/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000955%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000955/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12000955/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12000955/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40248726/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12000955/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40248726/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12000955/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12000955/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="pgYv5nyOpHdZwWvAMPyNS31DDkitFMIWufMvOevdbgBPYsSBWvmnbPUq6ExBPQZX">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
